This early-phase study tests whether placing bicalutamide implants directly into the prostate can replace standard hormone therapy (ADT) in men with localized prostate cancer who also receive radiation. About 20 participants will be enrolled. The goal is to see if this targeted a…
Phase: PHASE1 • Sponsor: Alessa Therapeutics Inc. • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC